1955年德国学者 Franke 与 Fuchus 二氏,Bertram 与他的同僚报告一种口服的磺胺制剂——Bz-55(其化学命名与化学构造式见图示),具有降低血糖的效用,在临床上可以替代胰岛素以治疗糖尿病,彼等的报告即刻引起了全世界各地医界人士乃至糖尿病患者的密切注意,现在,在德国已有数以千计的糖尿病患者正在接受 Bz-55,作为试验性的治疗,英、美、法、加拿大诸国家的临 1955 German scholar Franke and Fuchus two, Bertram and his colleagues reported an oral sulfa drug - Bz-55 (the chemical name and chemical structure shown in the figure), with the effect of reducing blood sugar, clinically possible Instead of insulin for the treatment of diabetes, their report immediately caught the attention of medical professionals and even diabetics around the world. Today, thousands of people with diabetes in Germany are receiving Bz-55 as a trial treatment, Britain, the United States, France, Canada’s various countries Pro